
Left, Ferrari Luce $645k Right, Nissan Leaf $35k
Joshua Fetzer
2.4K posts

@jrfetzer
I.T. Advisor & Fractional C.T.O.

Left, Ferrari Luce $645k Right, Nissan Leaf $35k






Eli Lilly released retatrutide Phase 3 data yesterday. 28% weight loss in 80 weeks. The most powerful obesity drug that’s ever been tested. And today the cancer signal drops. 12,112 patients. Seven tumor types. GLP-1 users had half the lung cancer metastasis rate (10% vs 22%). Breast cancer: 43% cut. Colon cancer five-year mortality in a separate study: 15.5% vs 37.1%. Cancer joins a list that already includes heart disease (SELECT, 20% MACE reduction), kidney failure (FLOW, 24% slower decline), sleep apnea (SURMOUNT-OSA, FDA-approved), addiction (BMJ, 600K veterans, 18-25% reduction across substances), and liver disease (86% fat clearance). Tumors express GLP-1 receptors. Activate them and NF-kB drops, apoptosis rises. The drug isn’t just shrinking fat. It’s talking directly to the cancer. One drug class. Designed for blood sugar. The biology keeps finding uses the designers didn’t predict.

Jeff Bezos on CNBC: "If people want me to pay more billions, then let's have that debate, but don't pretend that that's gonna solve the problem. You could double the taxes I pay, and it's not gonna help that teacher in Queens.... Airbnb isn't causing high rents. What's really causing high rent is government intervention."



Musk’s case against OpenAI dismissed after just two hours of jury deliberations ft.trib.al/Da4SqQq







